Results 11 to 20 of about 696 (142)

Epicutaneous immunotherapy for food allergy: A systematic review and meta‐analysis [PDF]

Clinical and Translational Allergy
Background Food allergies pose a global healthcare challenge, underscoring the need for effective interventions. This study evaluated the efficacy and safety of epicutaneous immunotherapy (EPIT) for food allergen desensitisation.
Péter Csonka, Bohee Lee, Ilari Kuitunen
doaj   +5 more sources

EAACI guidelines on the management of IgE-mediated food allergy. [PDF]

Allergy
This European Academy of Allergy and Clinical Immunology (EAACI) guideline provides recommendations for the management of IgE-mediated food allergy and was developed using the Grading of Recommendations, Assessment, Development and Evaluations (GRADE ...
Santos AF, Riggioni C, Agache I, Akdis CA, Akdis M, Alvarez-Perea A, Alvaro-Lozano M, Ballmer-Weber B, Barni S, Beyer K, Bindslev-Jensen C, Brough HA, Buyuktiryaki B, Chu D, Del Giacco S, Dunn-Galvin A, Eberlein B, Ebisawa M, Eigenmann P, Eiwegger T, Feeney M, Fernandez-Rivas M, Fiocchi A, Fisher HR, Fleischer DM, Giovannini M, Gray C, Hoffmann-Sommergruber K, Halken S, O'B Hourihane J, Jones CJ, Jutel M, Knol EF, Konstantinou GN, Lack G, Lau S, Mejias AM, Marchisotto MJ, Meyer R, Mortz CG, Moya B, Muraro A, Nilsson C, de Oliveira LCL, O'Mahony L, Papadopoulos NG, Perrett KP, Peters R, Podesta M, Poulsen LK, Roberts G, Sampson H, Schwarze J, Smith P, Tham E, Untersmayr E, Van Ree R, Venter C, Vickery B, Vlieg-Boerstra B, Werfel T, Worm M, Du Toit G, Skypala I.   +63 more
europepmc   +9 more sources

Estimated risk reduction to packaged food reactions by epicutaneous immunotherapy (EPIT) for peanut allergy [PDF]

Annals of Allergy, Asthma & Immunology, 2019
Peanut allergy is a generally persistent, sometimes life-threatening food allergy. With no treatments demonstrating the ability to cure a food allergy, the focus of drugs in development has been on providing a level of protection against accidental exposure reactions.
Benjamin C. Remington, Tanja Krone, Edwin Kim, J. Andrew Bird, Todd D. Green, Gideon Lack, David M. Fleischer, Stef J. Koppelman   +7 more
openalex   +6 more sources

Estimated Risk Reduction to Packaged Food Reactions by Epicutaneous Immunotherapy (EPIT) for Peanut Allergy [PDF]

Pediatrics, 2020
B Remington, T Krone, E Kim. Ann Allergy Asthma Immunol . 2019;123(5):488–493.e2 To estimate the relative risk reduction (RRR) when consuming peanut-contaminated packaged food products in children treated with epicutaneous immunotherapy (EPIT) for 12 months versus placebo.
Michael Tomani, Theresa Bingemann
openalex   +2 more sources

The safety and efficacy of oral immunotherapy compared to epicutaneous immunotherapy in peanut allergen desensitisation amongst the paediatric cohort—a narrative review [PDF]

Frontiers in Allergy
Peanut allergies result from a type 1 hypersensitivity reaction, with a prevalence of approximately 1% in children under 5 years of age. The allergens that instigate this reaction are the peanut proteins (Ara h 1–Ara h 8) for which IgE antibodies are ...
Ehtesam A. Chowdhury, Olivia C. Jadeja
doaj   +2 more sources

Treatment of eosinophilic gastritis by epicutaneous immunotherapy (EPIT) in peanut allergic piglets [PDF]

Journal of Allergy and Clinical Immunology, 2017
Treatment of eosinophilic gastritis by epicutaneous immunotherapy (EPIT) in peanut allergic piglets.
Lucie Mondoulet, Nicolas Kalach, Véronique Dhelft, Thibaut Larcher, Carine Delayre‐Orthez, Hugh A. Sampson, Benhamou, Pierre-Henri, Christophe Dupont   +7 more
  +6 more sources

Antigen Uptake by Langerhans Cells Is Required for the Induction of Regulatory T Cells and the Acquisition of Tolerance During Epicutaneous Immunotherapy in OVA-Sensitized Mice [PDF]

Frontiers in Immunology, 2018
The skin is a major immunologic organ that may induce protection, sensitization or tolerance. Epicutaneous immunotherapy (EPIT) has been proposed as an attractive strategy to actively treat food allergy and has been shown to induce tolerance in ...
Vincent Dioszeghy, Lucie Mondoulet, Leo Laoubi, Véronique Dhelft, Camille Plaquet, Adeline Bouzereau, Christophe Dupont, Hugh Sampson   +7 more
doaj   +3 more sources

Transitioning from epicutaneous to oral peanut immunotherapy [PDF]

Frontiers in Allergy, 2023
IntroductionEpicutaneous immunotherapy (EPIT) has been tested in clinical trials for children with peanut allergy (PA) for its safety and efficacy in inducing desensitization.
Lauren Wong, Laurie Kost, Brent Anderson, Andrew Long, Sayantani B. Sindher, R. Sharon Chinthrajah, William J. Collins, William J. Collins   +7 more
doaj   +2 more sources

Update on clinical research for food allergy treatment [PDF]

Frontiers in Allergy, 2023
The incidence of IgE-mediated food allergy (FA) has continued to increase over the years which places substantial burden on patient health and quality of life. With no cure for this disease, the mainstay of management has been allergen avoidance. However,
Joshua Fowler, Jay Lieberman
doaj   +2 more sources

Probiotics and other adjuvants in allergen-specific immunotherapy for food allergy: a comprehensive review [PDF]

Frontiers in Allergy
This review delves into the potential of manipulating the microbiome to enhance oral tolerance in food allergy, focusing on food allergen-specific immunotherapy (FA-AIT) and the use of adjuvants, with a significant emphasis on probiotics.
Maurizio Mennini, Marisa Piccirillo, Silvia Furio, Francesco Valitutti, Alessandro Ferretti, Caterina Strisciuglio, Maria De Filippo, Maria De Filippo, Pasquale Parisi, Diego Giampietro Peroni, Giovanni Di Nardo, Federica Ferrari   +11 more
doaj   +2 more sources